High valuations and competition for limited assets are seen as challenges; operational efficiency and expansion into new products/services will be the focus of capital investment.
NEW YORK – Anticipating high valuations and intense competition for limited high-value assets, healthcare and life science (HCLS) investors remain the most bullish they have been in the last three years, with nearly 80% of respondents indicating they plan to increase their M&A activity in 2025, particularly in areas such as life science tools and diagnostics and healthcare services according to new findings from the 2025 KPMG Healthcare and Life Sciences Investment Outlook.
“The era of smart optimism that defined deal activity in 2024 – companies needing to expand their capabilities through strategic acquisitions – has evolved to smart diligence in 2025,” says Kristin Pothier, U.S. Life Sciences Sector Leader and Global Healthcare and Life Sciences Deal Advisory Leader at KPMG. “Comprehensive commercial, operational, financial, and tax diligence will be critical for success and will enable seamless integrations that deliver value to patients. These trends are not only shaping the outlook for 2025; they are laying the groundwork for a future where healthcare and life sciences drive global innovation.”
The 2025 KPMG Healthcare and Life Sciences Outlook features insights from a survey of 500 industry executives and examines how deal activity and market drivers could influence the 2025 investment landscape of the HCLS sector.
Key Survey Findings Include:
Areas of Capital Deployment Focus for 2025
When it comes to deploying capital in 2025, improving operational efficiency, expanding into new products or services and platform expansion or bolt-on acquisitions are forecasted to be key capital deployment areas for HCLS respondents.
“As we head into 2025, the M&A train is picking up speed,“ said Ash Shehata, U.S. Healthcare Sector Leader at KPMG. “After a year of comparatively low deal activity, the industry is gearing up for a return to M&A. Although headwinds persist, we anticipate an uptick in deals driven by significant investments in generative AI, weight loss drugs and continued growth in the consumer health space.”
Select Subsector Highlights:
# # #
About KPMG LLP
KPMG LLP is the U.S. firm of the KPMG global organization of independent professional services firms providing audit, tax and advisory services. The KPMG global organization operates in 143 countries and territories and has more than 265,000 people working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such. KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients.
KPMG is widely recognized for being a great place to work and build a career. Our people share a sense of purpose in the work we do, and a strong commitment to community service, inclusion and diversity and eradicating childhood illiteracy. Learn more at www.kpmg.com/us.
For media inquiries, contact Marissa Ross (marissaross@kpmg.com) or Hannah O'Toole (hannahotoole@kpmg.com).
2024 Tax Reimagined: Perspectives from the C-Suite
9 in 10 C-suite leaders recognize their tax department as a pivotal contributor to enhancing trust among diverse stakeholders, according to the latest KPMG report.